ArticleExploratory research in clinical and social pharmacy2025
A descriptive report on the impact of pharmacy workflows in the operational success of hospital at home implementation at a county academic hospital system.
Article in Exploratory research in clinical and social pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The hospital at home (HaH) model has become more prevalent in the American healthcare system due to its ability to decrease acute care costs and readmission risk. Recent publications have provided guidance on optimizing medication management and patient safety by leveraging clinical pharmacy services. There is limited data on pharmacoeconomic impact of HaH implementation, specifically in underinsured patients. Objectives: To describe the development of HaH-related pharmacy workflows and evaluate the operational success of the program in an underinsured patient population. Methods: This report describes HaH program implementation between August 1st, 2022, and March 19th, 2024. Patients were eligible for home treatment if they met geographic, clinical, financial, and social criteria. Outcomes: The primary outcome measured was the quantity and cost of medication waste for patients treated at home. Secondary outcomes included HaH medication turnaround time, healthcare resource utilization, and patient safety. All study outcomes were reported using descriptive statistics. Results: Out of 450 patients screened, 3 met criteria and provided consent for HaH enrollment. The total cost of medication waste for all 3 patients was $41.15, and 21 out of 53 dispensed doses (40 %) were wasted. The mean medication verification time was 8.1 min, and the mean medication preparation time was 50.2 min. Conclusion: Study data provides insight into enhancing dispensing practices while establishing the benefits pharmacists bring to the HaH care team. Future research should elaborate on other measures of operational success to identify optimal performance metrics to support expanding pharmaceutical services within the HaH care model.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.